Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ESOMEPRAZOLE MAGNESIUM DIHYDRATE (PROCESS II), with a corresponding US DMF Number 27251.
Remarkably, this DMF maintains an Active status since its submission on September 17, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 27, 2013, and payment made on July 12, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II